Vaccine maker Moderna recently said it is hoping to sell a combined booster jab for infectious diseases such as COVID-19, influenza, and a common respiratory virus known as RSV.
The preliminary data from an Israeli study suggests that the fourth dose of the Pfizer-BioNTech vaccine is insufficient to prevent Omicron infection. Does this mean a fifth does is needed?
A research team has employed advanced computational simulations to study further, a protein that's essential to the replication of the virus, as well as remains comparatively consistent through different coronavirus variants.
The head of South Africa's Medical Research Council or SAMRC, Glenda Gray recently claimed that the COVID-19 vaccine booster shot developed by Johnson and Johnson has 85-percent efficacy.
Researchers recently developed a passive air sampler clip that can contribute to the assessment of personal exposure to the COVID-19 virus. This newly invented device could be particularly helpful for people working in high-risk environments like health care facilities and restaurants.
Some experts urge the public to upgrade cloth and surgical masks to N95 masks that are much more protective, although a shortage of supplies remains a concern.
The Beijing-based Chinese Academy of Sciences in Beijing has now discovered evidence that this new COVID-19 variant may have evolved its large collection of uncommon mutations in mice.
A new COVID-19 study confirmed that women could experience a slight delay in their menstrual cycle after being vaccinated, but experts say it is not clinically significant and do not pose any threat to women's health.
Hospitalizations due to COVID-19 remains at 90% three months after the booster shot, but UK health experts guarantee that the country will not see a big surge of cases in severe outcomes because booster shots help.
Experts say there are early, sketchy signals that the COVID-19 omicron wave has crested, or is plateauing, in the areas that were struck worst by the strain.